Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1992-5-27
|
pubmed:abstractText |
To examine the suggestion that s.c. administration of recombinant human erythropoietin (rHuEpo) may be more effective than i.v. administration, we changed the route of administration in 11 patients, previously established on a stable dose of rHuEpo given twice or thrice weekly, from i.v. to s.c. administration without altering the dose. All patients were iron replete (serum ferritin greater than 100 micrograms/l). In one patient the haemoglobin concentration declined at the time of conversion due to poor compliance, and another patient died shortly after conversion. In the remainder there was a significant increase in haemoglobin concentration from 9.30 (SD 0.78) at the time of conversion to 9.84 (0.59) at 1 month, 10.35 (1.22) at 2 months, and 10.39 (1.42) at 3 months. The increase in haemoglobin concentration was greater than 1 g/dl at 3 months in only five of the patients. Serum ferritin prior to conversion was similar in 'responders' and 'non-responders', but all responders had a transferrin saturation of greater than 16%, whereas three of four non-responders had transferrin saturation of less than or equal to 16%. Subcutaneous administration of rHuEpo is more effective, dose for dose, than i.v. administration, but poor iron mobilization may limit the response.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0931-0509
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
129-32
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1314972-Adult,
pubmed-meshheading:1314972-Anemia,
pubmed-meshheading:1314972-Erythropoietin,
pubmed-meshheading:1314972-Hemoglobins,
pubmed-meshheading:1314972-Humans,
pubmed-meshheading:1314972-Injections, Intravenous,
pubmed-meshheading:1314972-Injections, Subcutaneous,
pubmed-meshheading:1314972-Renal Dialysis
|
pubmed:year |
1992
|
pubmed:articleTitle |
Crossover comparison of intravenous and subcutaneous erythropoietin in haemodialysis patients.
|
pubmed:affiliation |
Department of Nephrology, Leicester General Hospital, UK.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|